Hide metadata

dc.date.accessioned2019-12-19T20:19:30Z
dc.date.available2019-12-19T20:19:30Z
dc.date.created2018-07-13T13:28:40Z
dc.date.issued2018
dc.identifier.citationHolm, Laurits J. Krogvold, Lars Hasselby, Jane P. Kaur, Simranjeet Claessens, Laura A. Russell, Mark A. Mathews, Clayton E. Hanssen, Kristian Folkvord Morgan, Noel G. Koeleman, Bobby P.C. Roep, Bart O. Gerling, Ivan C. Pociot, Flemming Dahl-Jørgensen, Knut Buschard, Karsten . Abnormal islet sphingolipid metabolism in type 1 diabetes. Diabetologia. 2018, 61(7), 1650-1661
dc.identifier.urihttp://hdl.handle.net/10852/71789
dc.description.abstractAims/hypothesis Sphingolipids play important roles in beta cell physiology, by regulating proinsulin folding and insulin secretion and in controlling apoptosis, as studied in animal models and cell cultures. Here we investigate whether sphingolipid metabolism may contribute to the pathogenesis of human type 1 diabetes and whether increasing the levels of the sphingolipid sulfatide would prevent models of diabetes in NOD mice. Methods We examined the amount and distribution of sulfatide in human pancreatic islets by immunohistochemistry, immunofluorescence and electron microscopy. Transcriptional analysis was used to evaluate expression of sphingolipid-related genes in isolated human islets. Genome-wide association studies (GWAS) and a T cell proliferation assay were used to identify type 1 diabetes related polymorphisms and test how these affect cellular islet autoimmunity. Finally, we treated NOD mice with fenofibrate, a known activator of sulfatide biosynthesis, to evaluate the effect on experimental autoimmune diabetes development. Results We found reduced amounts of sulfatide, 23% of the levels in control participants, in pancreatic islets of individuals with newly diagnosed type 1 diabetes, which were associated with reduced expression of enzymes involved in sphingolipid metabolism. Next, we discovered eight gene polymorphisms (ORMDL3, SPHK2, B4GALNT1, SLC1A5, GALC, PPARD, PPARG and B4GALT1) involved in sphingolipid metabolism that contribute to the genetic predisposition to type 1 diabetes. These gene polymorphisms correlated with the degree of cellular islet autoimmunity in a cohort of individuals with type 1 diabetes. Finally, using fenofibrate, which activates sulfatide biosynthesis, we completely prevented diabetes in NOD mice and even reversed the disease in half of otherwise diabetic animals. Conclusions/interpretation These results indicate that islet sphingolipid metabolism is abnormal in type 1 diabetes and suggest that modulation may represent a novel therapeutic approach.
dc.languageEN
dc.publisherSpringer Verlag
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleAbnormal islet sphingolipid metabolism in type 1 diabetes
dc.typeJournal article
dc.creator.authorHolm, Laurits J.
dc.creator.authorKrogvold, Lars
dc.creator.authorHasselby, Jane P.
dc.creator.authorKaur, Simranjeet
dc.creator.authorClaessens, Laura A.
dc.creator.authorRussell, Mark A.
dc.creator.authorMathews, Clayton E.
dc.creator.authorHanssen, Kristian Folkvord
dc.creator.authorMorgan, Noel G.
dc.creator.authorKoeleman, Bobby P.C.
dc.creator.authorRoep, Bart O.
dc.creator.authorGerling, Ivan C.
dc.creator.authorPociot, Flemming
dc.creator.authorDahl-Jørgensen, Knut
dc.creator.authorBuschard, Karsten
cristin.unitcode185,16,17,56
cristin.unitnameAvdeling for pedodonti og atferdsfag
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1597133
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Diabetologia&rft.volume=61&rft.spage=1650&rft.date=2018
dc.identifier.jtitleDiabetologia
dc.identifier.volume61
dc.identifier.issue7
dc.identifier.startpage1650
dc.identifier.endpage1661
dc.identifier.doihttps://doi.org/10.1007/s00125-018-4614-2
dc.identifier.urnURN:NBN:no-74885
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn0012-186X
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/71789/1/Holm_et_al_2018.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International